Who Just RaisedImmunophotonics, Inc.
St. Louis, MO ยท Pharmaceuticals
Immunophotonics, Inc. is a pharmaceuticals company based in St. Louis, Missouri. In a Form D filed with the SEC on September 4, 2026, it reported raising $10,147,612 from 45 investors as part of an offering of indefinite size. The first sale in the offering took place on July 14, 2025.
Immunophotonics' proprietary glycan polymer enhances antigen capture & immune processes, unlocking platform potential for immunotherapy.
- Website
- immunophotonics.com
- Amount raised
- $10,147,612
- Offering size
- Indefinite
- Investors so far
- 45
- Minimum investment
- $100,000
- First sale
- July 14, 2025
- Securities offered
- Equity
- Exemption claimed
- Rule 506(b)
- Industry
- Pharmaceuticals
- Headquarters
- St. Louis, Missouri
- Incorporated
- Delaware
- Entity type
- Corporation
Filings
| Filed | Form | Raised | Offering size | Investors | Source |
|---|---|---|---|---|---|
| D (new notice) | $10,147,612 | Indefinite | 45 | SEC filing |
Figures come from the company's own filing with the SEC and are shown as reported. How to read a Form D.
Other health care raises in Missouri
| Company | Location | Sector | Raised | Target | Filed |
|---|---|---|---|---|---|
| Charlestowne Senior Village LLC | Cottleville, MO | Health Care | $6.2M | $6.2M |